EUCTR2013-005399-16-ES进行中（未招募）不适用
Randomized, flexible-dose, open-label comparison to investigate the effectivenes of second generation antipsychotics in first episode psychosis patients. - second generation antipsychotics in first episode psychosis patients
Dr. Benedicto Crespo. Servicio Psiquiatría. Hospital Universitario Marqués de Valdecilla/IDIVA0 个研究点目标入组 200 人开始时间: 2014年6月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •From May 2014 to May 2016 all referrals to PAFIP were screened for patients who met the following criteria: 1) 15-60 years; 2) living in the catchment area; 3) experiencing their first episode of psychosis; 4) no prior treatment with antipsychotic medication or, if previously treated, a total life time of adequate antipsychotic treatment of less than 6 weeks; 5) DSM-IV criteria for brief psychotic disorder, schizophreniform disorder, schizophrenia, or schizoaffective disorder. The diagnoses were confirmed using the Structured Clinical Interview for DSM-IV (SCID ?I) (First et al., 2001) carried out by an experienced psychiatrist 6 months on from the baseline visit. Our operational definition for a ?first episode of psychosis? included individuals with a non-affective psychosis (meeting the inclusion criteria defined above) who have not received previously antipsychotic treatment regardless the duration of psychosis.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients were excluded for any of the following reasons: 1) meeting DSM-IV criteria for drug dependence, 2) meeting DSM-IV criteria for mental retardation, 3) having a history of neurological disease or head injury.
研究者
相似试验
已完成
不适用
.A.-I213 Acute transmural myocardial infarction of unspecified siteAcute transmural myocardial infarction of unspecified siteI213PER-003-98THE MEDICINES COMPANY, CAMBRIDGE M.A.,
Unknown
3 期
Study to evaluate the safety and efficacy of filgrastim in chemotherapy induced neutropeniaCTRI/2018/04/012992Virchow Biotech Private Limited
已完成
3 期
Study to evaluate the safety and efficacy of Pegfilgrastim in chemotherapy induced neutropeniaCTRI/2018/04/013221Virchow Biotech Private Limited150
招募中
不适用
Open-label, randomized comparative study to evaluate the pharmacokinetic characteristics of fenofibric acid between Lipidilsupra tablet andKCT0000323Hanmi Pharm28
招募中
3 期
A study to examine whether giving steroids in low dose daily is more effective than if given on alternate days, in controlling disease activity in patients with frequently relapsing nephrotic syndromeCTRI/2019/01/017091Indian Council of Medical Research